NASDAQ · LABTHealthcarePharmaceuticals

Lakewood-Amedex Biotherapeutics news

$0.1914−1.85%
Close Nov 4, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Lakewood-Amedex Biotherapeutics

No recent articles focused on Lakewood-Amedex Biotherapeutics.

Also mentions LABT

Articles that tag LABT but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology